Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Genitourinary 1

Conditions

Anemia 39Neoplasms 17Neoplasms, Plasma Cell 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Mycosis Fungoides 3Multiple Myeloma 3Monoclonal Gammopathy of Undetermined Significance 3Lymphoproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma 3Lung Neoplasms 3Leukemia, Prolymphocytic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Large Granular Lymphocytic 3Leukemia 3Immunoglobulin Light-chain Amyloidosis 3Immunoblastic Lymphadenopathy 3Hodgkin Disease 3Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Epoetin Alfa 3Surveys and Questionnaires 2Darbepoetin alfa 2stinging nettle lectin 1peppermint oil 1ofatumumab 1epoetin beta 1Sodium Chloride 1Ritonavir 1Quality of Life 1Physical Therapy Modalities 1Metformin 1Lenalidomide 1Holistic Health 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fatigue × Darbepoetin alfa × Classical hematology × Clear all
NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (AranespĀ®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

University of Aarhus

Phase 2/3 Terminated
140 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness

NCT00117039 2008-10-15

A Study to Evaluate the Effectiveness of AranespĀ® for Cancer Patients With Anemia

Amgen

Phase 4 Completed
1,500 enrolled
Classical hematology

Anemia, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔